Piper Sandler analyst Adam Maeder raised the price target on Edwards Lifesciences (NYSE: EW) to $105.00 (from $97.00) while maintaining a Overweight rating.

Analyst PT Change

Edwards Lifesciences (EW) PT Raised to $103 at Canaccord GenuityApril 21, 2021 8:26 AM Edwards Lifesciences (EW) PT Raised to $103 at StifelApril 21, 2021 8:16 AM Edwards Lifesciences (EW) PT Raised to $110 at JefferiesApril 21, 2021 8:09 AM Edwards Lifesciences (EW) PT Raised to $93 at Wells FargoApril 21, 2021 6:23 AM Edwards Lifesciences (EW) PT Raised to $108 at Morgan StanleyApril 21, 2021 3:57 AM After-Hours Stock Movers 04/20: (LRN) (EW) (ISRG) Higher; (NFLX) (ROKU) (FUBO) Lower (more...)April 20, 2021 5:20 PM Form 8-K Edwards Lifesciences For: Apr 20April 20, 2021 4:27 PM Edwards Lifesciences (EW) Tops Q1 EPS by 6c, Revenues Beat; Offers FY21 EPS OutlookApril 20, 2021 4:17 PM Edwards Lifesciences Reports First Quarter ResultsApril 20, 2021 4:15 PM